Having trouble viewing this email? View the content as a web page. | | REACH eBulletin Issued: 14 July 2021 | | HSE has received an Application for authorisation for the following substance/use: - 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (OPEO) (CAS: 9036-19-5). Use of 4-tert-OPnEO in the development of gene therapies.
Article 64 in the UK REACH Regulation makes provisions for HSE to obtain and use additional information on possible alternatives or technologies as part of the opinion forming process. HSE has announced a public consultation. View the details. Any third parties with an interest in the application are strongly encouraged to share any relevant information. Scientific and technical information on possible alternatives or technologies should be submitted directly to HSE using the commenting webform and templates by 8 September 2021. Non-confidential comments will be published on HSE's website. | | | |
Health and Safety Executive - 5N1 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS
No comments:
Post a Comment